Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Journal for Immunotherapy of Cancer
|
November 5, 2024
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures
Julijan Kabiljo, Anna Theophil, Jakob Homola, et al.
Nature Immunology
|
June 22, 2026
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains
Caitlin S Frazee, Sisi Chen, Corbett T Berry, et al.
Elife
|
April 3, 2019
Using parasite genetic and human mobility data to infer local and cross-border malaria connectivity in Southern Africa
Sofonias Tessema, Amy Wesolowski, Anna Chen, et al.
Journal of Medicinal Chemistry
|
October 6, 2021
Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with <i>In Vivo</i> Efficacy against MRSA
Yanran Lu, Sandip Vibhute, Linsen Li, et al.
Neuro-Oncology
|
January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
Kristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Cell Reports
|
June 1, 2022
Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy
Yannan Xi, Benbo Song, Iris Ngan, et al.
Blood Advances
|
April 8, 2025
Teclistamab for Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma and Renal Impairment
Danai Dima, Aimaz Afrough, Utkarsh Goel, et al.
Blood Cancer Discovery
|
July 9, 2025
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Blood Cancer Discovery
|
August 8, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Journal for Immunotherapy of Cancer
|
November 5, 2024
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures
Julijan Kabiljo, Anna Theophil, Jakob Homola, et al.
Nature Immunology
|
June 22, 2026
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains
Caitlin S Frazee, Sisi Chen, Corbett T Berry, et al.
Elife
|
April 3, 2019
Using parasite genetic and human mobility data to infer local and cross-border malaria connectivity in Southern Africa
Sofonias Tessema, Amy Wesolowski, Anna Chen, et al.
Journal of Medicinal Chemistry
|
October 6, 2021
Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with <i>In Vivo</i> Efficacy against MRSA
Yanran Lu, Sandip Vibhute, Linsen Li, et al.
Neuro-Oncology
|
January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
Kristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Cell Reports
|
June 1, 2022
Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy
Yannan Xi, Benbo Song, Iris Ngan, et al.
Blood Advances
|
April 8, 2025
Teclistamab for Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma and Renal Impairment
Danai Dima, Aimaz Afrough, Utkarsh Goel, et al.
Blood Cancer Discovery
|
July 9, 2025
Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Blood Cancer Discovery
|
August 8, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Beatrice M Razzo, Shonali Midha, Andrew J Portuguese, et al.
Page
of 15